drugset / Trial / NCT05617651

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

NCT05617651

Phase 1 Unknown 50 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluate the pharmacokinetic and safety of IY-NT-T in healthy adults

Timeline

Start
2024-11-30
Primary completion
2024-12-10
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ilaprazole Small molecule 10 mg
Comparator Ilaprazole Small molecule 20 mg

Indications

No indication recorded.